Gabelli Funds’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,262,487
Closed -$3.84M 1132
2024
Q4
$3.84M Buy
1,262,487
+171,323
+16% +$521K 0.03% 516
2024
Q3
$5.66M Buy
+1,091,164
New +$5.66M 0.04% 432